India to Peru: Everolimus Export Trade Route

The India to Peru Everolimus corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $440.1K USD. The route is dominated by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED , which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's everolimus manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $110.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with everolimus's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 20.7%, placing it at rank #6 among India's top everolimus export destinations globally.

On the import side, key buyers of Indian everolimus in Peru include DISDROSA, , O.C.S.A.C, OCSAC PERU. DISDROSA, is the single largest importer with 2 shipments valued at $254.2K USD.

India's everolimus exports to Peru are driven primarily by a handful of large-scale manufacturers. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED , TITAN LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $110.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as careverox 0.75 mg (everolimus tablets 0. and careverox 0.75 mg everolimus tablets 0.75 mg 1630 boxes of 3x10 = 48900 tablets, suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DISDROSA, is the largest importer with 2 shipments worth $254.2K USD — representing 58% of all everolimus imports from India on this route.